A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Primary Hyperlipidemia

In brief

This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

Key facts

Study ID
NCT06780410
Run by
Gan & Lee Pharmaceuticals.
People needed
240
Starts
2024-12-20
Expected to finish
2025-10-01
Last updated by the study team
2025-01-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.